procedure:maggot therapy
Othereach times in maggot therapy continued for three days.wound assessment was done before and after any intervention
Other names: larval therapy
NCT Number: NCT01681160
This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.
Looking for future studies?
Notify Me40 year–90 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
each times in maggot therapy continued for three days.wound assessment was done before and after any intervention
Other names: larval therapy
patients receive ordinary treatment for diabetic foot
Other names: mechanical debridement
Time frame: 2 years
Kerman Medical University
Other
Maggot Therapy in Diabetic Foot Ulcers
Acronym: MDT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07602491
Cardiovascular Diseases, Diabetes Complications
Cairo, Egypt
View Trial DetailsNCT07432581
Cardiovascular Diseases, Diabetes Complications
Cairo, Egypt
View Trial DetailsNCT01070433
Cardiovascular Diseases, Diabetes Complications
Phoenix, Arizona, United States
View Trial DetailsNCT01154374
Cardiovascular Diseases, Diabetes Complications
New Haven, Connecticut, United States
View Trial Details